GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and ...
Milestone Pharmaceuticals announced a Commercial Launch Plan investor event, indicating proactive engagement with investors and transparency about its upcoming strategies. The event will detail the ...
SAN DIEGO, March 2, 2020 /PRNewswire/ -- Neurelis, Inc., announced today the commercial availability of VALTOCO ® (diazepam nasal spray) for the acute treatment of intermittent, stereotypic episodes ...
Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback